Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis

abstract

Conclusion(s)

The majority of women with Type I EOC displayed assay sensitivity to at least one agent. Given the small sample size these findings need to be evaluated further.

Highlights

•

Multi-drug resistance was more likely in women with Type I compared to Type II cancers.

•

The majority of women with Type I epithelial ovarian cancer displayed assay sensitivity to at least one chemotherapeutic agent in a chemoresponse assay.

•

PFS was significantly worse in women with Type II EOC with resistant compared to non-resistant chemoresponse assay results for carboplatin.